MAbSilico is a French deeptech startup that designs and implements computational solutions for therapeutic antibodies and biodrugs discovery and development. It is based in Nouzilly, France. It was founded on Sep 25, 2017.
Artificial Intelligence, Biotechnology, Health Care, Life Science
No funding announced yet
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as MAbSilico? We’re happy to assist you with our Startup Sourcing service.